# 2026-22555: Animal Health Company Seeks Federal Pentobarbital Import Approval

2026-22555, Importer of Controlled Substances Application: Diamond Animal Health, Inc., is a Federal Register notice from Justice Department, Drug Enforcement Administration published 2026-11-05, effective Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 7, 2026. Such persons may also file a written request for a hearing on the application on or before December 7, 2026.; PRIA reads it as touching household money (as of 2026-11-06).

- Canonical: https://policyrisk.com/federal-register/2026-22555
- As of: 2026-11-06
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2026-22555
- Title: Importer of Controlled Substances Application: Diamond Animal Health, Inc.
- Type: Notice
- Agencies: Justice Department; Drug Enforcement Administration
- Citation: 91 FR 69885
- Published: 2026-11-05
- Effective: Registered bulk manufacturers of the affected basic class(es), and applicants, therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before December 7, 2026. Such persons may also file a written request for a hearing on the application on or before December 7, 2026.
- Comments close: 2026-12-07
- Significant: no
- Touches household money: yes
- Regulation identifier numbers: none
- Last updated: 2026-11-06

## In one line

Animal Health Company Seeks Federal Pentobarbital Import Approval

## Summary

Diamond Animal Health, Inc. wants to become an official importer of a controlled drug called Pentobarbital, which is used in animal health. People who make or use these drugs can share their thoughts or ask for a hearing by December 7, 2026. This move could affect businesses handling these substances and involves careful government review but no direct costs mentioned yet.

## Abstract

Diamond Animal Health, Inc., has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

## Effects PRIA read

- Application to Import Pentobarbital Filed: mixed, low. On February 19, 2026, Diamond Animal Health, Inc. applied to be registered to import pentobarbital (controlled substance code 2270, Schedule II). The application states the import would support manufacture of the Schedule III (N) finished dosage form Euthasol.
- Import Use Limited to Euthasol Manufacture: cost, low. The notice states the company plans to import pentobarbital specifically to support manufacture of the Schedule III (N) finished dosage form Euthasol and that no other activity for this drug code is authorized under the registration.
- No Authorization to Import Finished Dosage Forms for Sale: cost, medium. The agency states that authorization will not extend to the import of Food and Drug Administration‑approved or non‑approved finished dosage forms for commercial sale. This prohibition applies to finished-dose products rather than bulk pentobarbital for manufacture.

## Related documents

- [2026-11526](https://policyrisk.com/federal-register/2026-11526): Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 201…, 2026-06-09
- [2026-10128](https://policyrisk.com/federal-register/2026-10128): Revision of Applications for Manufacturing and Procurement Quotas, 2026-05-20
- [2025-05007](https://policyrisk.com/federal-register/2025-05007): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-03-24
- [2025-02793](https://policyrisk.com/federal-register/2025-02793): Expansion of Buprenorphine Treatment via Telemedicine Encounter and Continuity of Care via Telemedicine for Veterans Affairs Patients, 2025-02-19
- [2026-22553](https://policyrisk.com/federal-register/2026-22553): Importer of Controlled Substances Application: Noramco, 2026-11-05
- [2026-22289](https://policyrisk.com/federal-register/2026-22289): Bulk Manufacturer of Controlled Substances Application: AJNA Biosciences, 2026-11-02

## Sources
- [2026-22555 on federalregister.gov](https://www.federalregister.gov/documents/2026/11/05/2026-22555/importer-of-controlled-substances-application-diamond-animal-health-inc)
- [2026-22555 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2026-11-05/pdf/2026-22555.pdf)

## Related
- [Previous: 2026-22554, Tribal Intergovernmental Advisory Committee Request for Member Nominations; Ext…](https://policyrisk.com/federal-register/2026-22554)
- [Next: 2026-22556, Bulk Manufacturer of Controlled Substances Application: Navinta LLC](https://policyrisk.com/federal-register/2026-22556)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2026-22555 (as of 2026-11-06).